July 5, 2011 -- Wetzlar, Germany. Leica Microsystems announces the release of the Leica SCN400 F combined fluo-rescent and brightfield digital slide scanner. The SCN400 F brings together Leica’s award winning brightfield slide scanning capabilities and multi-channel fluorescence imaging in a single platform, providing versatility to researchers and core laboratories utilizing Digital Pathology.
By employing two separate illumination and scanning methods, the Leica SCN400 F ensures excellent brightfield scans and crisp multi-channel fluorescent images from one device. Scanned slides are readily re¬viewed online through the SlidePath Digital Image Hub web-viewer, incorporating the ability to turn on and off separate channels with the click of a button to examine each marker individually.
To view a sample fluorescent image, please visit our Virtual Slide Gallery at www.leica-microsystems.com/products/digital-pathology.
Dr. Donal O’Shea, Head of Digital Pathology in Leica Microsystems says, “The Leica SCN400 F is a significant breakthrough for researchers looking for an affordable solution for scanning brightfield and fluorescent slides. With the ever growing adoption of immunofluorescent staining in research to study multi-marker co-expression in oncology and neuroscience, we see the SCN400 F as a valuable tool for core laboratories, bringing increased efficiency and quality to research practices.”
The Leica SCN400 F is the newest scanning solution in the Total Digital Pathology portfolio, demon-strating Leica’s drive and innovation in this market. Leica Microsystems’ broad range of interoperable Digital Pathology components provides customers with the flexibility to choose the solution that is right for their needs.
Leica Microsystems is a world leader in microscopes and scientific instruments. Founded as a family business in the nineteenth century, the company’s history was marked by unparalleled innovation on its way to becoming a global enterprise.
Its historically close cooperation with the scientific community is the key to Leica Microsystems’ tradition of innovation, which draws on users’ ideas and creates solutions tailored to their requirements. At the global level, Leica Microsystems is organized in four divisions, all of which are among the leaders in their respective fields: the Life Science Division, Industry Division, Biosystems Division and Medical Division.
Leica Microsystems’ Biosystems Division, also known as Leica Biosystems, offers histopathology labo-ratories the most extensive product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory.
The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers. The company is head-quartered in Wetzlar, Germany.